Vivasvan Vykunta

27 posts

Vivasvan Vykunta

Vivasvan Vykunta

@VivaVykunta

MD-PhD Student @UCSF_MSTP with @MaxKrummel | Previously @MarsonLab @GladstoneInst and Zikherman Lab @UCSF | @PDSoros Fellow '26 | Immuno-engineering and biking

California Katılım Eylül 2021
126 Takip Edilen96 Takipçiler
Vivasvan Vykunta retweetledi
nature
nature@Nature·
Nature research paper: Submicrometre sampling of living cells by macrophages go.nature.com/4cZs2Gv
English
2
16
71
13.5K
Vivasvan Vykunta
Vivasvan Vykunta@VivaVykunta·
I'm honored to be among this year's @PDSoros Fellows! Check out the new cohort and all they've accomplished: pdsoros.org/meet-the-class… Immensely grateful to @MaxKrummel, Alex Marson, @brshy, Julie Zikherman and many many more mentors who took a chance on me early in my training!
PD Soros Fellowships@PDSoros

Today, we announced the 2026 Fellows—we hope you will read their incredible stories and learn about their work! Selected from 3,000+ applications, it was the most competitive year in our history. pdsoros.org/meet-the-class…

English
0
2
8
849
Vivasvan Vykunta retweetledi
Roth_Lab
Roth_Lab@Roth_Lab·
Excited to present the first major work after starting our lab at Stanford and the Arc this year: CRISPR-All, a unified genetic perturbation language for programming any major type of genetic perturbation simultaneously, in any combination, at genome scale, in human cells.
English
9
102
401
154.3K
Vivasvan Vykunta retweetledi
Justin Eyquem
Justin Eyquem@j_eyquem·
🚨Excited to share our latest work, now out in @NatureBiotech ! We introduce SEED-Selection, a powerful method that enables high-efficiency enrichment of T cells edited at multiple loci in a single step 🧵👇 🔗 nature.com/articles/s4158…
English
10
38
133
18K
Vivasvan Vykunta retweetledi
Nature Biotechnology
Nature Biotechnology@NatureBiotech·
SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci go.nature.com/4gBnaqY
Nature Biotechnology tweet media
English
2
25
84
9.7K
Vivasvan Vykunta
Vivasvan Vykunta@VivaVykunta·
Excited to share this new piece! From taking art classes together back in grade school and visiting colleges together in high school to now being co-first authors, I'm looking forward to continue working and learning with @rishabrama in our future training and careers!
Rishab Ramapriyan, MD@rishabrama

Excited to share our new review on altered cancer metabolism and implications for next-generation CAR T-cell therapies-- written with @VivaVykunta @GustVandeca @LGKRichardson @WTCNeuroscience @BryanDChoi @MGHNeurosurg Full Paper: authors.elsevier.com/a/1j8rTbEXZb8Dd

English
0
1
6
1.2K
Vivasvan Vykunta
Vivasvan Vykunta@VivaVykunta·
First paper from my time in @UCSF_MSTP is out today @SciImmunology! Had a blast learning from and working with @MarcoDegiov89 and the whole Cyster Lab @UCSF -- looking forward to seeing how the De Giovanni Lab continues this work!
De Giovanni Lab@MarcoDegiov89

Excited to share our latest results published in @SciImmunology unravelling how mast cells control dendritic cell positioning to sustain intestinal IgA production #Cysterlab @ArmeniseHarvard @SanRaffaeleMI @UCSF science.org/doi/10.1126/sc…

English
1
1
15
1.4K
Vivasvan Vykunta retweetledi
Justin Eyquem
Justin Eyquem@j_eyquem·
🚨 New study for the lab! We developed SEED selection, a method to purify KnockIns at multiple loci in a single step. Better, It takes no space in the donor template, can be easily multiplexed and its all through negative selection! 👏👏 @ChrisRChang biorxiv.org/content/10.110…
English
2
18
85
8.6K
Vivasvan Vykunta retweetledi
Nature Immunology
Nature Immunology@NatImmunol·
Zikherman and colleagues describe a new mechanism by which B cells recognize virus-like antigen display as a stand-alone danger signal that does not rely exclusively on avidity and BCR cross-linking. Read it here: rdcu.be/dlGBQ #Abs1" target="_blank" rel="nofollow noopener">nature.com/articles/s4159…
English
1
18
45
10.6K
Vivasvan Vykunta retweetledi
Edward Nirenberg 🇺🇦
Edward Nirenberg 🇺🇦@ENirenberg·
I am so glad someone finally published on the mechanism by which high valency antigens induce better B cell responses than soluble ones rdcu.be/dlvFO
English
0
2
7
1.7K
Vivasvan Vykunta
Vivasvan Vykunta@VivaVykunta·
Great to see this published and thankful to have played a small part in this story during my time with @MarsonLab! Enjoyed working with my previous roommate, Dan, to develop ideas together -- Excited to see how this new tech impacts the genome engineering space!!
Ross Wilson@RossWilsonLab

I’m excited to share our report - out now in @natBME - of a new approach to CRISPR delivery that is poised to transform the way engineered T cell therapies are manufactured. Visit tinyurl.com/CRISPR-PERC for “how to” details. It’s threadin’ time! (1/11) nature.com/articles/s4155…

English
0
0
6
578
Vivasvan Vykunta retweetledi
Masopust Vezys Lab
Masopust Vezys Lab@Masopust_Vezys·
Authored by Andrew G. Soerens et al, we show that #Tcells are capable of proliferating in response to iterative stimulation for over 10yrs! And produce enough progeny to occupy a volume 30,000x the Earth's volume! @Nature nature.com/articles/s4158…
English
35
383
1.4K
545.2K
Vivasvan Vykunta retweetledi
Nature Biotechnology
Nature Biotechnology@NatureBiotech·
Combinations of single-stranded DNA repair templates and small molecules markedly enhance genome editing go.nature.com/3dS9NYC
English
0
24
70
0